Oral prostaglandin E2 for the management of ductus dependent congenital heart diseases. Is there a role for home therapy?
Department of Neonatology, Shaare Zedek Medical Center, Israel.
Y
Y
Schlesinger
M S
MS
Schimmel
A I
AI
Eidelman
Y
Y
Glaser
D015232:Dinoprostone / Q000008:administration & dosage*; D004374:Ductus Arteriosus, Patent / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male
D015232:Dinoprostone